Meta-Analysis

Recently published articles about Meta-Analysis

JCP
Burnout in Psychiatric Doctors Before and After the COVID-19 Pandemic
Meta-Analysis

September 29, 2025

The prevalence of burnout was 37.5% prior to the COVID-19 pandemic and 32.0% following the pandemic.
, ,
JCP
Treating PTSD in Military Populations
Meta-Analysis

March 24, 2025

Integrating psychotherapies and pharmacotherapies may address multiple dimensions of PTSD more effectively than monotherapies.
, , , et al
JCP
Changes in Cognition in Patients With Schizophrenia
Meta-Analysis

September 25, 2024

Only marginal improvements in cognition were seen over time; the greatest were achieved for patients with an illness duration shorter than 10 years.
, , , et al
PCC
rTMS in Depression, Schizophrenia, and OCD
Meta-Analysis

September 26, 2023

In treatment-resistant depression, repetitive transcranial magnetic stimulation had higher odds of response and remission rates compared to sham.
, , , et al
JCP
Omega-3 PUFA Supplements for ADHD
Meta-Analysis

August 30, 2023

Although omega-3 polyunsaturated fatty acids (PUFAs) may not improve core symptoms of attention-deficit/hyperactivity disorder, longer-term PUFA supplementation may have potential benefits.
, , , et al
JCP
Mechanisms of Treatment of Bipolar Disorder and Borderline Personality Disorder: Brain Imaging Research
Meta-Analysis

March 27, 2023

Different brain regions were changed with psychotherapy versus medication. The findings may help with predicting treatment efficacy and identifying treatment biomarkers in these disorders.
, , , et al

Recent JCP Articles on Meta-Analysis

JCP
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
Commentary

October 6, 2025

The authors assert that while valproate remains invaluable for certain severe conditions, the high risk of teratogenicity means stringent safeguards are needed to regulate its use by individuals capable...
, , , et al
JCP
Esmethadone (REL-1017) in Patients with Major Depressive Disorder and Antidepressant Tachyphylaxis
Original Research

October 6, 2025

Esmethadone may be a potentially safe and effective adjunctive treatment for patients with MDD and antidepressant tachyphylaxis.
, , , et al
JCP
Symptom Network Analysis of ADHD and Emotional Symptoms in Adults
Original Research

October 1, 2025

Emotional dysregulation symptoms play a significant role in connecting the core ADHD symptoms, particularly those related to the inattention dimension.
, , , et al

Recent PCC Articles on Meta-Analysis

PCC
Mosaic Turner Syndrome and Schizophrenia
Case Report

October 7, 2025

This case adds to the literature on Turner syndrome and psychosis and is an example of the heterogeneity of individuals who meet the criteria for treatment-resistant schizophrenia.
, ,
PCC
When a Headache Isn’t Just a Headache
Case Report

October 7, 2025

A 70-year-old woman experienced progressive headache and systemic symptoms after several days of high-dose ibuprofen administration.
, , , et al
PCC
Access to Primary Care in First-Episode Psychosis
Original Research

October 2, 2025

Improving engagement in primary care is critical for young adults with first-episode psychosis to establish beneficial patterns of health care use and timely access to preventative care.
, , , et al

Featured Meta-Analysis Research

Hair Loss Drug Exacts a Mental Health Toll Decades in the Making
news

October 7, 2025

A new review links the hair loss drug finasteride to depression and suicide, blaming decades of regulatory and corporate neglect.
Motherhood Switches On Dormant Aggression Circuit
news

October 6, 2025

Motherhood “switches on” a dormant aggression circuit in the brain, a hormone-sensitive network that evolution repurposed to defend offspring.
Two Genetic Paths Dictate Timing of Autism Diagnosis
news

October 3, 2025

A landmark international study reveals that early- and late-diagnosed autism follow distinct developmental and genetic pathways.

Watch the New PsychCase360

Explore two real-world schizophrenia cases
Promotional banner for a video titled “Choosing the Right LAI for Patients With Schizophrenia” featuring headshots of Roueen Rafeyan, MD, and Melissa Vitale, PMHNP, with a “Watch Now” button.

Subscribe to read
more articles

Subscribe